+143.3%
MRNA vs UEC
-7.4%
+150.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | UEC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -2.4% | -0.9% | -1.7% |
| 7D | -10.1% | -0.2% | -9.9% | -10.1% |
| 30D | +126.7% | +1.9% | +124.8% | +125.5% |
| 3M | +184.1% | +8.9% | +175.2% | +175.5% |
| 6M | +143.3% | -14.5% | +157.7% | +136.4% |
| All | +143.3% | -7.4% | +150.7% | +136.4% |
Cumulative growth
Daily Returns
Daily percentage return beside UEC.
Daily Out/Under-Performance
Portfolio return minus UEC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × UEC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded UEC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling